Reclassifying tumour cell cycle activity in terms of its tissue of origin
Abstract Genomic alterations resulting in loss of control over the cell cycle is a fundamental hallmark of human malignancies. Whilst pan-cancer studies have broadly assessed tumour genomics and their impact on oncogenic pathways, analyses taking the baseline signalling levels in normal tissue into...
Main Authors: | Arian Lundberg, Joan Jong Jing Yi, Linda S. Lindström, Nicholas P. Tobin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-022-00302-7 |
Similar Items
-
Systemic vasculitis--is it time to reclassify?
by: Watts, R, et al.
Published: (2011) -
Reclassifying housing delivery delay classification
by: Chang, Saar Chai, et al.
Published: (2013) -
Reclassifying Inflammatory Bowel Disease with Capsule Endoscopy in Children
by: Shruti Shree Joshi, et al.
Published: (2013-09-01) -
SEM approach: Reclassifying housing delay in Malaysian housing industry
by: Chai, Chang Saar, et al.
Published: (2015) -
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
by: Julien Calderaro, et al.
Published: (2023-12-01)